Biodiversity Literature Repository
Published February 1, 2023 | Version v1
Journal article Open

A large-scale study on the seroprevalence of Toxoplasma gondii infection in humans in Iran

Creators

  • 1. Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; & Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran;
  • 2. Department of Medical Parasitology and Mycology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran;
  • 3. Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; & Acquired Immunodeficiency Research Centre, Isfahan University of Medical Sciences.
  • 4. Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;

Description

Kalantari, Reza, Esmaeilifallah, Mahsa, Jafari, Rasool, Esfahani, Hossein Mirhendi, Darani, Hossein Yousofi (2023): A large-scale study on the seroprevalence of Toxoplasma gondii infection in humans in Iran. Folia Parasitologica (004) 70: 1-8, DOI: 10.14411/fp.2023.004, URL: http://dx.doi.org/10.14411/fp.2023.004

Files

source.pdf

Files (2.2 MB)

Name Size Download all
md5:b62bfabc984a5740974f64ad29cfc0b0
2.2 MB Preview Download

Linked records

Additional details

Identifiers

LSID
urn:lsid:plazi.org:pub:B62BFFBC984A5740974FFFADFFCFFFB0

Related works

Has part
Dataset: http://table.plazi.org/id/96C4665A984B574197D8FF10FD83FEBD (URL)
Figure: 10.5281/zenodo.8143744 (DOI)
Figure: 10.5281/zenodo.8143746 (DOI)
Figure: 10.5281/zenodo.8143748 (DOI)
Dataset: http://table.plazi.org/id/96C4665A984F574597D8FF16FAEFFF60 (URL)

References

  • AGUIRRE A.A., LONGCORE T., BARBIERI M., DABRITZ H., HILL D., KLEIN P.N., LEPCZYK C., LILLY E.L., MCLEOD R., MILCARSKY J., MURPHY C.E., SU C., VANWORMER E., YOLKEN R., SIZEMORE G.C. 2019: The One Health approach to toxoplasmosis: epidemiology, control, and prevention strategies. Ecohealth 16: 378-390.
  • AHMADPOUR E., DARYANI A., SHARIF M., SARVI S., AARABI M., MIZANI A., RAHIMI M.T., SHOKRI A. 2014: Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J. Infect. Dev. Ctries. 8: 1503-1510.
  • ALMERIA S., CANO-TERRIZA D., PRIETO P., DUBEY J.P., JIMENEZ-MARTIN D., CASTRO-SCHOLTEN S., PANIAGUA J., GARCIA-BOCANEGRA I. 2021: Seroprevalence and risk factors of Toxoplasma gondii infection in wild ungulates that cohabit in a natural park with human-animal interaction in the Mediterranean ecosystem. Zoonoses Public Health 68: 263-270.
  • ASGARI Q., MOTAZEDIAN M.H., KHAZANCHIN A., MEHRABANI D., NADERI SHAHABADI S. 2021: High prevalence of Toxoplasma gondii infection in type I Diabetic patients. J. Parasitol. Res. 2021: 8881908.
  • ATTIAS M., TEIXEIRA D.E., BENCHIMOL M., VOMMARO R.C., CREPALDI P.H., DE SOUZA W. 2020:The life-cycle of Toxoplasma gondii reviewed using animations. Parasit. Vectors 13: 588.
  • BEN-HARARI R.R., CONNOLLY M.P. 2019: High burden and low awareness of toxoplasmosis in the United States. Postgrad. Med. J. 131: 103-108.
  • DAHER D., SHAGHLIL A., SOBH E., HAMIE M., HASSAN M.E., MOUMNEH M.B., ITANI S., EL HAJJ R., TAWK L., EL SABBAN M., EL HAJJ H. 2021: Comprehensive overview of Toxoplasma gondii -induced and associated diseases. Pathogens 10:1351.
  • DARYANI A., SARVI S., AARABI M., MIZANI A., AHMADPOUR E., SHOKRI A., RAHIMI M.T., SHARIF M. 2014: Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 137: 185-194.
  • DUBEY J.P., JONES J.L. 2008: Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 38: 1257-1278. egative and susceptible to infection. Therefore, individuals at high risk should be monitored. Several measures will aid in the prevention and control of T. gondii infection. These include health policies targeting the promotion of public educational programs, training courses for childbearing age and pregnant women, an inspection of food production industries, improvement of hygienic standards of abattoirs, and sanitary disposal of viscera.
  • FOROUTAN M., DALVAND S., DARYANI A., AHMADPOUR E., MAJIDIANI H., KHADEMVATAN S., ABBASI E. 2019: Rolling up the pieces of a puzzle: a systematic review and meta-analysis of the prevalence of toxoplasmosis in Iran. Alexandria J. Med. 54: 189-196.
  • HILL D.E., DUBEY J.P. 2018: Toxoplasma gondii. In: Y.R. Ortega and C.R. Sterling (Eds.), Foodborne Parasites. Springer, Cham, pp. 119-138.
  • HLAVAcOVA J., FLEGR J., FIURASKOVA K., KANKOVA S. 2021: Relationship between latent toxoplasmosis and depression in clients of a center for assisted reproduction. Pathogens 10: 1052.
  • HOSSEINI S.A., SHARIF M., SARVI S., JANBABAI G., KEIHANIAN S., ABEDIANKENARI S., GHOLAMI S., AMOUEI A., JAVIDNIA J., SABERI R., SHEKARRIZ R., DARYANI A. 2021: Toxoplasmosis among cancer patients undergoing chemotherapy: a population study based on the serological, molecular and epidemiological aspects. Trans. R. Soc. Trop. Med. Hyg. 115: 677-686.
  • INCEBOZ M., INCEBOZ T. 2021: Toxoplasmosis and neuropsychological effects. Turkiye Parazitol. Derg. 45: 49-55.
  • KALOGEROPOULOS D., SAKKAS H., MOHAMMED B., VARTHOLOMATOS G., MALAMOS K., SREEKANTAM S., KANAVAROS P., KALOGEROPOULOS C. 2021: Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int. Ophthalmol. 42: 295-321.
  • KHADEMI S.Z., GHAFFARIFAR F., DALIMI A., DAVOODIAN P., ABDOLI A. 2019: Prevalence and risk factors of Toxoplasma gondii infection among pregnant women in Hormozgan province, south of Iran. Iran. J. Parasitol. 14: 167-173.
  • KHOSRAVI S, ESLAMIRAD Z., RAFIEI F. 2016: The overview on studies related to the prevalence of neonatal toxoplasmosis in Iran. Iran. J. Clin. Infect. Dis. 3: 91-96.
  • MENDOZA-LARIOS L.A., GARCIA-DOLORES F., SANCHEZ-ANGUIANO L.F., HERNANDEZ-TINOCO J., ALVARADO-ESQUIVEL C. 2021: Association between suicide and Toxoplasma gondii seropositivity. Pathogens 10: 1094.
  • MOLAN A N.K., HUNTER M, WANG W. 2019: Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop. Biomed. 36: 898-925.
  • MONTOYA J.G., LIESENFELD O. 2004: Toxoplasmosis. Lancet 363: 1965-1976.
  • MOSHFE A., AREFKHAH N., SARKARI B., KAZEMI S., MARDANI A. 2018: Toxoplasma gondii in blood donors: a study in Boyer-Ahmad county, southwest Iran. Interdiscip. Perspect. Infect. Dis. 2018: 3813612.
  • MOUSAVI-HASANZADEH M., SARMADIAN H., GHASEMIKHAH R., DIDEHDAR M., SHAHDOUST M., MALEKI M., TAHERI M. 2020: Evaluation of Toxoplasma gondii infection in western Iran: seroepidemiology and risk factors analysis. Trop. Med. Health 48: 35.
  • NAHVI M., SHOJAEE S., KESHAVARZ H., SALIMI M., MOHEBALI M. 2019: Detection of Toxoplasma gondii in cord blood samples from neonates in Tehran, Iran. Iran. J. Public Health 48: 912-916.
  • NAYERI T., SARVI S., MOOSAZADEH M., AMOUEI A., HOSSEININEJAD Z., DARYANI A. 2020: The global seroprevalence of anti- Toxoplasma gondii antibodies in women who had spontaneous abortion: a systematic review and meta-analysis. PLOS Negl. Trop. Dis. 14: e0008103.
  • NAYERI T., SARVI S., SHARIF M., DARYANI A. 2021: Toxoplasma gondii: a possible etiologic agent for Alzheimer's disease. Heliyon 7: e07151.
  • RASTI S., HASSANZADEH M., SOLIEMANI A., HOOSHYAR H., MOUSAVI S.G., NIKOUEINEJAD H., ABDOLI A. 2016: Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran. Ren. Fail. 38: 970-973.
  • ROBERT-GANGNEUX F., DARDE M.L. 2012: Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 25: 264-296.
  • ROBERTS T., MURRELL K.D., MARKS S. 1994: Economic losses caused by foodborne parasitic diseases. Parasitol. Today 10: 419-423.
  • SAKI J., ESKANDARI E., FEGHHI M. 2020: Study of toxoplasmosis and toxocariasis in patients suffering from ophthalmic disorders using serological and molecular methods. Int. Ophthalmol. 40: 2151-2157.
  • SOBATI H. 2020: Chemiluminescent microparticle immunoassay-based detection and prevalence of Toxoplasma gondii infection in childbearing women (Iran). J. Parasit. Dis. 44: 273- 280.
  • THEBAULT A., KOOH P., CADAVEZ V., GONZALES-BARRON U., VILLENA I. 2021: Risk factors for sporadic toxoplasmosis: a systematic review and meta-analysis. Microb. Risk Anal. 17: 100116.
  • TORGERSON P.R., MASTROIACOVO P. 2013: The global burden of congenital toxoplasmosis: a systematic review. Bull. World Health Organ. 91: 501-508.
  • WEISS L.M., DUBEY J.P. 2009: Toxoplasmosis: a history of clinical observations. Int. J. Parasitol. 39: 895-901.